Hyderabad-based pharmaceutical company Natco Pharma on Thursday said the board of directors will consider a proposal for buyback of fully paid-up equity shares of the face value of the company. 2 on every Wednesday, March 8, 2023.
“A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, March 8, 2023, to consider, inter alia, a proposal for buyback of fully paid-up shares common share of a company of face value of Rs. 2 each as well as related/relevant cases,” the pharmaceutical firm said in an exchange filing.
Natco Pharma22 percent decline in consolidated net profit of 62 crores for the third quarter ending December 31, 2022. The Hyderabad-based pharmaceutical company had reported a net profit of Rs. 80 crore in the October-December quarter of the last financial year.
stood on the total income of the company 513 crore in the period under review as compared to Rs. 591 crore in the year-ago period which included one-time licensing revenue.
The Board of the company has also approved an interim dividend of Rs. 1.25 per share for the quarter ending December 31, 2022.
Shares of the company closed with a gain of 2.44 per cent. 551.80 per share today on BSE.
Know your inner investor
Do you have guts of steel or are you a victim of insomnia regarding your investments? Let’s define your investment approach.
catch all business News, market news, today’s fresh news events and Breaking News Update on Live Mint. download mint news app To get daily market updates.